Ten Hypermethylated lncRNA Genes Are Specifically Involved in the Initiation, Progression, and Lymphatic and Peritoneal Metastasis of Epithelial Ovarian Cancerстатья
Статья опубликована в высокорейтинговом журнале
Статья опубликована в журнале из списка Web of Science и/или Scopus
Аннотация:Abstract:OurworkaimedtoevaluateanddifferentiatetheroleoftenlncRNAgenes(GAS5,HAND2AS1,KCNK15-AS1,MAGI2-AS3,MEG3,SEMA3B-AS1,SNHG6,SSTR5-AS1,ZEB1-AS1,andZNF667-AS1) in the development and progression of epithelial ovarian cancer (EOC). Are presentative set of clinical samples was used: 140 primary tumors from patients without and with metastases and 59 peritoneal metastases. Using MS-qPCR, we demonstrated an increase in methylation level so fall ten lncRNA genes in tumors compared to normal tissues (p < 0.001). Using RT-qPCR, we showed down regulation and an inverse relationship between methylation and expression levels for ten lncRNAs (rs <−0.5). We further identified lncRNA genes that were specifically hypermethylated in tumors from patients with metastasestolymphnodes(HAND2-AS1),peritoneum(KCNK15-AS1,MEG3,andSEMA3B-AS1),and greateromentum(MEG3,SEMA3B-AS1,andZNF667-AS1). The same four lncRNAgenesinvolvedin peritonealspreadwereassociatedwithclinicalstageandtumorextent(p<0.001). Interestingly, we found areversionfromincreasetodecreaseinthehypermethylationleveloffivemetastasis-relatedlncRNA genes (MEG3, SEMA3B-AS1, SSTR5-AS1, ZEB1-AS1, and ZNF667-AS1) in 59 peritoneal metastases. This reversion may be associated with partial epithelial–mesenchymal transition(EMT) in metastatic cells,asindicatedbyadecreaseintheleveloftheEMTmarker,CDH1mRNA(p<0.01). Furthermore, novel mRNA targets and regulated miRNAs were predicted for a number of the studied lncRNAsusing the NCBIGEO data sets and analyzed by RT-qPCR and transfection of SKOV3 and OVCAR3 cells. In addition, hypermethylation of SEMA3B-AS1,SSTR5-AS1,andZNF667-AS1geneswasproposedasa marker for overall survival in patients with EOC.